Investigation of DRD2 and HTR2A mRNA Expression in Two Therapeutic States of Antipsychotic Polypharmacy and Aripiprazole Monotherapy in the Peripheral Blood of Patients With Schizophrenia
Objectives: Schizophrenia is a severe psychiatric disorder that has profound effects on both individuals and the community. Notwithstanding the suggestion for treating schizophrenia with a minimum dose of drugs, antipsychotic polypharmacy increases the patient’s care costs and drug interactions. Ari...
Main Authors: | Arash Mirabzadeh, Hamid Reza Iranpour, Hamid Reza Khorram Khorshid, Davood Zare-Abdollahi, Mehdi Norouzi, Venus Vatankhah |
---|---|
Format: | Article |
Language: | English |
Published: |
Negah Institute for Scientific Communication
2020-09-01
|
Series: | Iranian Rehabilitation Journal |
Subjects: | |
Online Access: | http://irj.uswr.ac.ir/article-1-1052-en.pdf |
Similar Items
-
Determination of Changes in Blood Biomarker Levels in Antipsychotic Polypharmacy and Aripiprazole Monotherapy in Patients With Long-term Schizophrenia
by: Venus Vatankhah, et al.
Published: (2019-12-01) -
Emotional Intelligence in Carriers of Different СОМТ, BDNF, DRD2 and HTR2A Genotypes
by: Elena V. Vorobyeva, et al.
Published: (2022-06-01) -
Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia
by: Narges Taheri, et al.
Published: (2023-10-01) -
Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis
by: Andrea Miuli, et al.
Published: (2020-04-01) -
Individual and simultaneous treatment with antipsychotic aripiprazole and antidepressant trazodone inhibit sterol biosynthesis in the adult brain
by: Marta Balog, et al.
Published: (2022-08-01)